Czasopismo Clinical and Experimental Hepatology 2021

Non-alcoholic fatty liver disease and lipotoxicity

Natalia Wasilewska, Dariusz Marek Lebensztejn

DOI: https://doi.org/10.5114/ceh.2021.104441

Abstract View text

Should patients with unresectable gallbladder cancer with hilar involvement undergo unilateral or bilateral percutaneous biliary drainage in the setting of cholangitis?

Pankaj Gupta, Varun Bansal, Naveen Kalra, Jayanta Samanta, Harshal Mandavdhare, Vishal Sharma, Usha Dutta, Rakesh Kochhar, Manavjit Singh Sandhu

DOI: https://doi.org/10.5114/ceh.2021.104674

Abstract View text

Influence of ursodeoxycholic acid therapy on levels of fibroblast growth factor 21, adiponectin and biochemical parameters in intrahepatic cholestasis of pregnancy

Michał Kukla, Rafał Kierach, Magdalena Skonieczna, Dorota Hudy, Krzysztof Dąbrowski, Tomasz Menżyk, Aleksandra Derra, Dariusz Boroń, Beniamin Oskar Grabarek

DOI: https://doi.org/10.5114/ceh.2021.104419

Abstract View text

The association between obstructive sleep apnea and non-alcoholic steatohepatitis: a retrospective nationwide inpatient sample analysis

Anas Renno, Yousef Abdel-Aziz, Yaseen Alastal, Sadik Khuder, Syed Hasan, Ragheb Assaly, Ali Nawras

DOI: https://doi.org/10.5114/ceh.2021.104488

Abstract View text

Taurine mitigates bile duct obstruction-associated cholemic nephropathy: effect on oxidative stress and mitochondrial parameters

Narges Abdoli, Issa Sadeghian, Negar Azarpira, Mohammad Mehdi Ommati, Reza Heidari

DOI: https://doi.org/10.5114/ceh.2021.104675

Abstract View text

The usefulness of immunohistochemical staining of bile tracts in biliary atresia

Joanna Cielecka-Kuszyk, Maria Janowska, Małgorzata Markiewicz, Piotr Czubkowski, Anna Ostoja-Chyżyńska, Joanna Beata Bierła, Bożena Cukrowska, Joanna Pawłowska

DOI: https://doi.org/10.5114/ceh.2021.104676

Abstract View text

Predictors of azathioprine toxicity in children with autoimmune hepatitis

Behairy El-Sayed Behairy, Hala Hany El-Said, Hatem Abd-Alsattar Konswa, Ahmed El-Sayed Nour El-Deen, Nermin Mohamed Adawy, Ahmad Mohamed Sira

DOI: https://doi.org/10.5114/ceh.2021.104634

Abstract View text

Comparative study of the effects of Abexol and atorvastatin in patients with non-alcoholic fatty liver disease

Caridad Ruenes Domech, Julio Cesar Fernandez Travieso, Zaily Dorta Guridi, Marlen Ivón Castellanos Fernández, Sacha Lazo del Vallín, Anaisa Rojas Carralero, Elena Ferrer Batallie, Aimeé Marcia Alvarez Alvarez, Lilia Fernández Dorta, José Illnait Ferrer, Sarahi Mendoza Castaño, Maytee Robaina García, Gladys Jiménez Rivero, Yeni Veliz Alvarez

DOI: https://doi.org/10.5114/ceh.2021.104387

Abstract View text

Hepatocellular carcinoma recurrence after directly acting antivirals for chronic hepatitis C: a 2-year follow-up study

Ahmed Kamal, Amr Aly Abd Elmoety, Yousri Abdelmeguid Rostom, Mohamed Said Shater, Sameh Aldesoky Lashen

DOI: https://doi.org/10.5114/ceh.2021.104397

Abstract View text

Galectin-3 is not useful for hepatocellular carcinoma surveillance in cirrhotic patients but it may be a marker of cirrhosis development

Eman Saad Nassar, Yomna Abdelrazek Elkalbashawy, Ahmed Kamal, Nermine Hossam Eldin Zakaria

DOI: https://doi.org/10.5114/ceh.2021.104385

Abstract View text

Clinical aspects and treatment of hepatocellular carcinoma in north-eastern Poland

Tadeusz Wojciech Łapiński, Aleksandr Tarasik, Marcin Januszkiewicz, Robert Flisiak

DOI: https://doi.org/10.5114/ceh.2021.104631

Abstract View text

Assessment of hepatitis B virus pregenomic RNA in high and low viremic chronic hepatitis B patients

Aymen Farid Elshayeb, Mohamed Gamal Abdrabu, Sara Lotfy Asar, Mohamed Adel Abdelaziz, Hossam Abuelkheir

DOI: https://doi.org/10.5114/ceh.2021.104472

Abstract View text

Change in γ-glutamyl transpeptidase activity as a useful tool in identifying a group of patients with elevated risk of hepatocellular carcinoma development after DAA treatment of chronic hepatitis C

Dorota Orzechowska, Katarzyna Klimowicz, Anna Stępień, Tomasz Mikuła, Mariusz Sapuła, Alicja Wiercińska-Drapało

DOI: https://doi.org/10.5114/ceh.2021.104466

Abstract View text

Characterization of CD326-positive human hepatic stem cells

Eva Schmelzer, Giada Pietrosi, Bruno Gridelli, Jörg Gerlach

DOI: https://doi.org/10.5114/ceh.2021.104459

Abstract View text

FIB-4 and APRI scores for predicting severe liver fibrosis in chronic hepatitis HCV patients: a monocentric retrospective study

Roberto Catanzaro, Alice Aleo, Morena Sciuto, Luca Zanoli, Baskar Balakrishnan, Francesco Marotta

DOI: https://doi.org/10.5114/ceh.2021.104543

Abstract View text

Brain-derived neurotrophic factor as a potential diagnostic marker in minimal hepatic encephalopathy

Agnieszka Stawicka, Magdalena Świderska, Justyna Zbrzeźniak, Natalia Sołowianowicz, Aleksandra Woszczenko, Robert Flisiak, Jerzy Jaroszewicz

DOI: https://doi.org/10.5114/ceh.2021.103242

Abstract View text

Non-alcoholic fatty liver disease and lipotoxicity

Should patients with unresectable gallbladder cancer with hilar involvement undergo unilateral or bilateral percutaneous biliary drainage in the setting of cholangitis?

Influence of ursodeoxycholic acid therapy on levels of fibroblast growth factor 21, adiponectin and biochemical parameters in intrahepatic cholestasis of pregnancy

The association between obstructive sleep apnea and non-alcoholic steatohepatitis: a retrospective nationwide inpatient sample analysis

Taurine mitigates bile duct obstruction-associated cholemic nephropathy: effect on oxidative stress and mitochondrial parameters

The usefulness of immunohistochemical staining of bile tracts in biliary atresia

Predictors of azathioprine toxicity in children with autoimmune hepatitis

Comparative study of the effects of Abexol and atorvastatin in patients with non-alcoholic fatty liver disease

Hepatocellular carcinoma recurrence after directly acting antivirals for chronic hepatitis C: a 2-year follow-up study

Galectin-3 is not useful for hepatocellular carcinoma surveillance in cirrhotic patients but it may be a marker of cirrhosis development

Clinical aspects and treatment of hepatocellular carcinoma in north-eastern Poland

Assessment of hepatitis B virus pregenomic RNA in high and low viremic chronic hepatitis B patients

Change in γ-glutamyl transpeptidase activity as a useful tool in identifying a group of patients with elevated risk of hepatocellular carcinoma development after DAA treatment of chronic hepatitis C

Characterization of CD326-positive human hepatic stem cells

FIB-4 and APRI scores for predicting severe liver fibrosis in chronic hepatitis HCV patients: a monocentric retrospective study

Brain-derived neurotrophic factor as a potential diagnostic marker in minimal hepatic encephalopathy

Coverage in

Integrated with

Editorial Policies